Newly approved myasthenia gravis drug shows sustained benefits in early respondersNovember 15, 2023Myasthenia GravisRare DiseasesNeuromuscular Disorders
Chemotherapy-induced peripheral neuropathy tied to compromised executive functionNovember 15, 2023Neuromuscular DisordersNeuro-oncology
Artificial intelligence presents opportunities, challenges in neurologic practiceNovember 14, 2023Business of MedicineNeuromuscular DisordersAlzheimer's & CognitionEpilepsy & SeizuresHeadache & MigraineMovement DisordersMultiple Sclerosis
U.S. study finds unexpectedly high prevalence of myasthenia gravisNovember 8, 2023Myasthenia GravisNeuromuscular DisordersRare Diseases
‘Hidden’ cognitive impairments in DMD may worsen outcomesNovember 8, 2023Neuromuscular DisordersRare Diseases
First new treatment in 30 years for rare disease is effective, tolerable, convenientNovember 8, 2023Rare DiseasesNeuromuscular Disorders
Duchenne muscular dystrophy gene therapy safe, effective at 4 yearsNovember 7, 2023PediatricsRare DiseasesNeuromuscular Disorders
Genetic therapies bring change to neurology clinicsNovember 6, 2023Neuromuscular DisordersGene Therapy
In myasthenia gravis, antibodies pass open-label testsNovember 3, 2023Myasthenia GravisNeuromuscular DisordersRare DiseasesPediatrics
FDA okays drug for Duchenne muscular dystrophyOctober 30, 2023Neuromuscular DisordersRare DiseasesPediatrics
Stiff person syndrome: When a rare disorder hits the headlinesOctober 13, 2023Neuromuscular Disorders
Emerging therapies in Duchenne and facioscapulohumeral muscular dystrophyOctober 13, 2023Rare DiseasesNeuromuscular Disorders
Has prompt diagnosis of amyotrophic lateral sclerosis become urgent?October 13, 2023Rare DiseasesNeuromuscular Disorders
Are cellular therapies the future of autoimmune disease?September 28, 2023Neuromuscular DisordersMultiple Sclerosis
